View in EDS

Durvalumab-containing treatment for recurrent or metastatic pulmonary sarcomatoid carcinoma: A pooled post hoc analysis of two KCSG phase II trials.

Saved in:
Bibliographic Details
Title: Durvalumab-containing treatment for recurrent or metastatic pulmonary sarcomatoid carcinoma: A pooled post hoc analysis of two KCSG phase II trials.
Authors: Kim DH; Department of Internal Medicine, Seoul National University Hospital, Seoul, the Republic of Korea; Department of Translational Medicine, Seoul National University College of Medicine, Seoul, the Republic of Korea., Kim M; Department of Internal Medicine, Seoul National University Hospital, Seoul, the Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, the Republic of Korea., Youk J; Department of Internal Medicine, Seoul National University Hospital, Seoul, the Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, the Republic of Korea., Kim TM; Department of Internal Medicine, Seoul National University Hospital, Seoul, the Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, the Republic of Korea., Lee GW; Division of Hematology and Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Institute of Medical Science, Gyeongsang National University College of Medicine, Jinju, the Republic of Korea., Kim SH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, the Republic of Korea., Kim YJ; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, the Republic of Korea., Kim JS; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, the Republic of Korea., Hong SH; Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, the Republic of Korea., Ahn MS; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, the Republic of Korea., Shin SH; Department of Internal Medicine, Kosin University Gospel Hospital, Busan, the Republic of Korea., Kim DW; Department of Internal Medicine, Seoul National University Hospital, Seoul, the Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, the Republic of Korea., Kim JH; Department of Internal Medicine, CHA Bundang Medical Center, Seongnam, the Republic of Korea., Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul, the Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, the Republic of Korea. Electronic address: bhumsuk@snu.ac.kr.
Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2026 Mar; Vol. 213, pp. 108916. Date of Electronic Publication: 2026 Jan 11.
Publication Type: Journal Article; Clinical Trial, Phase II
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41529377
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Durvalumab-containing treatment for recurrent or metastatic pulmonary sarcomatoid carcinoma: A pooled post hoc analysis of two KCSG phase II trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kim+DH%22">Kim DH</searchLink>; Department of Internal Medicine, Seoul National University Hospital, Seoul, the Republic of Korea; Department of Translational Medicine, Seoul National University College of Medicine, Seoul, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+M%22">Kim M</searchLink>; Department of Internal Medicine, Seoul National University Hospital, Seoul, the Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Youk+J%22">Youk J</searchLink>; Department of Internal Medicine, Seoul National University Hospital, Seoul, the Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+TM%22">Kim TM</searchLink>; Department of Internal Medicine, Seoul National University Hospital, Seoul, the Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+GW%22">Lee GW</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Institute of Medical Science, Gyeongsang National University College of Medicine, Jinju, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+SH%22">Kim SH</searchLink>; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+YJ%22">Kim YJ</searchLink>; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+JS%22">Kim JS</searchLink>; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Hong+SH%22">Hong SH</searchLink>; Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Ahn+MS%22">Ahn MS</searchLink>; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Shin+SH%22">Shin SH</searchLink>; Department of Internal Medicine, Kosin University Gospel Hospital, Busan, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+DW%22">Kim DW</searchLink>; Department of Internal Medicine, Seoul National University Hospital, Seoul, the Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+JH%22">Kim JH</searchLink>; Department of Internal Medicine, CHA Bundang Medical Center, Seongnam, the Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Keam+B%22">Keam B</searchLink>; Department of Internal Medicine, Seoul National University Hospital, Seoul, the Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, the Republic of Korea. Electronic address: bhumsuk@snu.ac.kr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228800805%22">Lung cancer (Amsterdam, Netherlands)</searchLink> [Lung Cancer] 2026 Mar; Vol. 213, pp. 108916. <i>Date of Electronic Publication: </i>2026 Jan 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Scientific+Publishers%22">Elsevier Scientific Publishers </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>8800805 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-8332 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201695002%22">01695002 </searchLink><i>NLM ISO Abbreviation: </i>Lung Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41529377
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.lungcan.2026.108916
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 108916
    Titles:
      – TitleFull: Durvalumab-containing treatment for recurrent or metastatic pulmonary sarcomatoid carcinoma: A pooled post hoc analysis of two KCSG phase II trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kim DH
      – PersonEntity:
          Name:
            NameFull: Kim M
      – PersonEntity:
          Name:
            NameFull: Youk J
      – PersonEntity:
          Name:
            NameFull: Kim TM
      – PersonEntity:
          Name:
            NameFull: Lee GW
      – PersonEntity:
          Name:
            NameFull: Kim SH
      – PersonEntity:
          Name:
            NameFull: Kim YJ
      – PersonEntity:
          Name:
            NameFull: Kim JS
      – PersonEntity:
          Name:
            NameFull: Hong SH
      – PersonEntity:
          Name:
            NameFull: Ahn MS
      – PersonEntity:
          Name:
            NameFull: Shin SH
      – PersonEntity:
          Name:
            NameFull: Kim DW
      – PersonEntity:
          Name:
            NameFull: Kim JH
      – PersonEntity:
          Name:
            NameFull: Keam B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1872-8332
          Numbering:
            – Type: volume
              Value: 213
          Titles:
            – TitleFull: Lung cancer (Amsterdam, Netherlands)
              Type: main
ResultId 1